Effect of long-term treatment with D-NAME and L-NAME with or without L-arginine on cardiovascular system in rats

Biologia - Section Cellular and Molecular Biology

Volumn 55, Issue SUPPL. 8, 2000, Pages 5-8

  Babál, Pavel ^a   Danihel, L'udovít ^a   Pecháňová, Ol'ga ^b   Bernátová, Iveta ^b  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Arterial hyperplasia; D NAME; Hypertension; L arginine; L NAME; Myocardial fibrosis; Nitric oxide synthase

Indexed keywords

RATTUS NORVEGICUS;

EID: 0009039220     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. ARNAL, J. F., EL AMRANI, A. I., CHATELLIER, G., MENARD, J. & MICHEL J. B. 1993. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387.
2. BABAL, P., PECHÁŇOVÁ, O., BERNÁTOVÁ, I. & ŠTVRTINA, S. 1997. Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia. Histol. Histopathol. 12: 623-629.
3. BABÁL, P., PECHÁNOVÁ, O. & BERNÁTOVÁ, I. 2000. Long-term administration of D-NAME induces hemodynamic and structural changes in the cardiovascular system. Physiol. Res. 49: 47-54.
4. BREDT, D. S. & SNYDER, S. H. 1990. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682-685.
5. CHINELLATO, A., FROLDI, G., CAPARROTTA, L. & RAGAZZI, E. 1998. Pharmacological characterization of endothelial cell nitric oxide synthase inhibitors in isolated rabbit aorta. Life Sciences 62: 479-490.
6. NUMAGUCHI, K., EGASHIRA, K., TAKEMOTO, M., KADOKAMI, T., SHIMOKAWA, H., SUEISHI, K. & TAKESHITA, A. 1995. Chronic inhibition of nitric oxide synthesis caused coronary microvascular remodeling in rats. Hypertension 26[part 1]: 957-962.
7. PALMER, R. M. J., REES, D. D., ASHTON, D. S. & MONCADA, S. 1988. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153: 1251-1256.
8. PECHÁŇOVÁ, O., BERNÁTOVÁ, I., PELOUCH, V. & ŠIMKO, F. 1997. Protein remodeling of the heart in NO-deficient hypertension: the effect of captopril. J. Mol. Cell. Cardiol. 29: 3365-3365.
9. REES, D. D., PALMER, R. M. J., SCHULTZ, R., HODSON, H. F. & MONCADA, S. 1990. Characterization of three inhibitors of endothelial nitric oxide synthesis in vitro and in vivo. Br. J. Pharmacol. 101: 746-752.
10. TURNER, C. H., OWAN, I., JACOB, D. S., MCCLINTOCK, R. & PEACOCK, M. 1997. Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 21: 487-490.
11. USUI, M., EGASHIRA, K., KITAMOTO, S., KOZANAGI, M., KATOH, M., KATAOKA, C., SHIMOKAWA, H., TAKESHIT, A. A. 1999. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension. 34: 546-551.
12. G-nitro-arginine in conscious rats are antagonized by L-but not D-arginine. Eur. J. Pharmacol. 200: 77-81.